GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lavipharm SA (ATH:LAVI) » Definitions » Total Tax Payable

Lavipharm (ATH:LAVI) Total Tax Payable : €0.65 Mil (As of Jun. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Lavipharm Total Tax Payable?

Lavipharm's Total Tax Payable for the quarter that ended in Jun. 2024 was €0.65 Mil.

Lavipharm's quarterly Total Tax Payable declined from Jun. 2023 (€0.81 Mil) to Dec. 2023 (€0.59 Mil) but then increased from Dec. 2023 (€0.59 Mil) to Jun. 2024 (€0.65 Mil).

Lavipharm's annual Total Tax Payable increased from Dec. 2021 (€0.89 Mil) to Dec. 2022 (€1.81 Mil) but then declined from Dec. 2022 (€1.81 Mil) to Dec. 2023 (€0.59 Mil).


Lavipharm Total Tax Payable Historical Data

The historical data trend for Lavipharm's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lavipharm Total Tax Payable Chart

Lavipharm Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Tax Payable
Get a 7-Day Free Trial 0.77 1.04 0.89 1.81 0.59

Lavipharm Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.95 1.81 0.81 0.59 0.65

Lavipharm Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.


Lavipharm Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Lavipharm's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Lavipharm Business Description

Traded in Other Exchanges
Address
Agias Marinas Street, PO Box 59, Peania Attica, GRC, 19002
Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Lavipharm Headlines

No Headlines